Citation Impact
Citing Papers
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children
2013
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
2006
Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party.
1993
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent Asthma
1998
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
1998
Mediators of nasal blockage in allergic rbtis
1997
Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma
2001
Enhanced Superoxide Production by Alveolar Macrophages and Air-Space Cells, Airway Inflammation, and Alveolar Macrophage Density Changes after Segmental Antigen Bronchoprovocation in Allergic Subjects
1992
Cellular and molecular mechanisms of fibrosis
2007 Standout
Neurogenic Inflammation and Asthma
1992
Neural influences on synovial mast cell density in rat
1990
S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway
2007
Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis
2014
Budesonide and Formoterol in a Single Inhaler Improves Asthma Control Compared With Increasing the Dose of Corticosteroid in Adults With Mild-to-Moderate Asthma
2003
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Systemic reactions occurring during immunotherapy with standardized pollen extracts
1992
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders
1994
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
2003
The control of allergens of dust mites and domestic pets: a position paper
1992
Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)
2000
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Inhaled Glucocorticoids for Asthma
1995
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients
1996
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
1999
Anandamide – the other side of the coin
2000 StandoutNobel
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Immediate and Late Inflammatory Responses to Ragweed Antigen Challenge of the Peripheral Airways in Allergic Asthmatics: Cellular, Mediator, and Permeability Changes
1991
β-Adrenergic Bronchodilators
1995
Long-Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells
2007
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial
2004
Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction
1989
NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS
2005
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators
1998
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Asthma
2017 Standout
When can personal best peak flow be determined for asthma action plans?
2004
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
Circadian variation of sputum inflammatory cells in mild asthma
2003
Long-Acting β<SUB>2</SUB>-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Long-acting ?2-agonists in management of childhood asthma: A critical review of the literature
2000
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents
1992 Standout
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
Circadian control of the immune system
2013 Standout
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
2007
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
2005
Asthma
2001 Standout
The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma
1987
Fluticasone at different doses for chronic asthma in adults and children
2005
Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis
1994
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma
1997
Inhaled and nasal corticosteroids: safety aspects*
2000
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
2006
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
2005 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Hydrogen sulphide and its therapeutic potential
2007 Standout
Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.
1989
The Pathophysiology and Treatment of Sepsis
2003 Standout
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
2003
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Asthma exacerbations {middle dot} 4: Prevention
2006
Pharmacological strategies for self-management of asthma exacerbations: Table 1—
2006
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma
1997
Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin
1989
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds
2005
Regulation of Adrenergic Receptor Responsiveness Through Modulation of Receptor Gene Expression
1991 StandoutNobel
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
2002 Standout
A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses
1990
Long-term Repeatability of Induced Sputum Cells and Inflammatory Markers in Stable, Moderately Severe COPDa
2003
House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study
2000
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma Receiving Salmeterol<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils.
1994
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction
2001
Asthma
2000 Standout
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
2000
Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography
1997 Standout
Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma
2004
Induced Sputum Cellularity
2000
Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma
1998
Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma
2006
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
1999
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics
1998
A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma
2000
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Asthma
2005
Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with Asthma
1998
Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma
1999
Choosing a Long-term Controller Medication in Childhood Asthma
1997
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist
2002
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
2001
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Laboratory Investigation of Deaths Due to Anaphylaxis
1991
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Adrenergic therapy of bronchial asthma
1986
Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients
1996
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils.
1991
Guidelines for management of asthma at primary and secondary levels of health care in India (2005).
2005
Release of Prostaglandin D2into Human Airways during Acute Antigen Challenge
1986
Long- and Short-Acting ß2-Adrenergic Agonists
1996
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Immunotherapy as an effective tool in allergy treatment
1998
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Position Paper: Immunotherapy
1993
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
2005
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Fluticasone at different doses for chronic asthma in adults and children
2008
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
2000
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.
1982
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Malondialdehyde in Exhaled Breath Condensate as a Marker of Oxidative Stress in Different Pulmonary Diseases
2011
Effect of substance P on superoxide anion and IL-8 production by human PMNL.
1994
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Prostaglandins and Inflammation
2011 Standout
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids.
1996
Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators
1997
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of P.W. Ind being referenced
Absence of circulating products of oxygen derived free radicals in acute severe asthma
1989
Safety of formoterol by Turbuhaler® as reliever medication compared with terbutaline in moderate asthma
2002
Adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study
2004
Bronchial hyperresponsiveness in patients recovering from acute severe asthma
1993
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
1994
Induced sputum to assess airway inflammation: a study of reproducibility
1997
A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics
1982
Sputum induction
2002
Increased concentrations of cyclic 3′,5′‐adenosine monophosphate without a physiological response after antidiuretic hormone
1971
Concentration effect relationships of infused histamine in normal volunteers
1982
Inhaled prazosin in asthma.
1981
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex
1986
A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals
1980
A large volume spacer significantly reduces the effect of inhaled steroids on bone formation
1995
Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite
1988
Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma
2003
Measurement of plasma histamine in asthma
1983